145 related articles for article (PubMed ID: 31217579)
1. Management of primary pterygium with intra-lesional injection of 5 flurouracil and bevacizumab (Avastin).
Ghoz N; Britton J; Ross AR; Mohammed I; Hogan E; Said DG; Dua HS
Eye (Lond); 2019 Nov; 33(11):1776-1783. PubMed ID: 31217579
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium.
Bekibele CO; Sarimiye TF; Ogundipe A; Olaniyan S
Eye (Lond); 2016 Apr; 30(4):515-21. PubMed ID: 26987589
[TBL] [Abstract][Full Text] [Related]
3. Intra-lesional 5 fluorouracil for the management of recurrent pterygium.
Said DG; Faraj LA; Elalfy MS; Yeung A; Miri A; Fares U; Otri AM; Rahman I; Maharajan S; Dua HS
Eye (Lond); 2013 Oct; 27(10):1123-9. PubMed ID: 23807385
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients.
Singh P; Sarkar L; Sethi HS; Gupta VS
Indian J Ophthalmol; 2015 Oct; 63(10):779-84. PubMed ID: 26655003
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF) in macrophages, fibroblasts, and endothelial cells in pterygium treated with 5-Fluorouracil.
Hoyama E; Viveiros MM; Shiratori C; de Oliveira DE; Padovani CR; Selva D; Schellini SA
Semin Ophthalmol; 2015 May; 30(3):171-6. PubMed ID: 24171833
[TBL] [Abstract][Full Text] [Related]
6. Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injections.
García Tirado A; Boto de Los Bueis A; Rivas Jara L
Eur J Ophthalmol; 2019 Jan; 29(1):9-14. PubMed ID: 29580102
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
Enkvetchakul O; Thanathanee O; Rangsin R; Lekhanont K; Suwan-Apichon O
Cornea; 2011 Nov; 30(11):1213-8. PubMed ID: 21915047
[TBL] [Abstract][Full Text] [Related]
8. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.
Nava-Castañeda A; Olvera-Morales O; Ramos-Castellon C; Garnica-Hayashi L; Garfias Y
Clin Exp Ophthalmol; 2014 Apr; 42(3):235-41. PubMed ID: 23777441
[TBL] [Abstract][Full Text] [Related]
9. Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis.
Zeng W; Liu Z; Dai H; Yan M; Luo H; Ke M; Cai X
BMC Ophthalmol; 2017 Nov; 17(1):211. PubMed ID: 29178848
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of subconjunctival bevacizumab in primary pterygium excision.
Razeghinejad MR; Hosseini H; Ahmadi F; Rahat F; Eghbal H
Ophthalmic Res; 2010; 43(3):134-8. PubMed ID: 19887878
[TBL] [Abstract][Full Text] [Related]
11. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study.
Chua BE; Nguyen DQ; Qin Q; Ruddle JB; Wells AP; Niyadurupola N; Gupta V; Wong TT; Coote MA; Crowston JG
Clin Exp Ophthalmol; 2012 Nov; 40(8):773-9. PubMed ID: 22429268
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intralesional bevacizumab administration in primary pterygium: a quantitative analysis.
Sarac O; Demirel S; Oltulu R
Eye Contact Lens; 2014 Jan; 40(1):46-50. PubMed ID: 24335454
[TBL] [Abstract][Full Text] [Related]
13. Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study.
Mohamed TA; Soliman W; Fathalla AM; El Refaie A
Int J Ophthalmol; 2018; 11(5):797-801. PubMed ID: 29862178
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite.
Lee BWH; Sidhu AS; Francis IC; Coroneo MT
Ocul Surf; 2022 Oct; 26():128-141. PubMed ID: 35961535
[TBL] [Abstract][Full Text] [Related]
15. Halting pterygium recurrence by postoperative 5-fluorouracil.
Pikkel J; Porges Y; Ophir A
Cornea; 2001 Mar; 20(2):168-71. PubMed ID: 11248822
[TBL] [Abstract][Full Text] [Related]
16. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF
Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
Prabhasawat P; Tesavibul N; Leelapatranura K; Phonjan T
Ophthalmology; 2006 Jul; 113(7):1102-9. PubMed ID: 16730066
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
Hwang S; Choi S
Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pterygium by ligation and bevacizumab injection.
Nakasato H; Uemoto R; Mizuki N
Cornea; 2012 Nov; 31(11):1339-41. PubMed ID: 22710493
[TBL] [Abstract][Full Text] [Related]
20. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
